Modeling sequence - Sequence interactions for drug response

Bioinformatics

Volumn 23, Issue 10, 2007, Pages 1251-1257

  Lin, Min ^a,c   Li, Hongying ^a   Hou, Wei ^b   Johnson, Julie A ^b   Wu, Rongling ^a  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DNA; DOBUTAMINE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG RESEARCH; DRUG RESPONSE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC EPISTASIS; HAPLOTYPE MAP; HEART RATE VARIABILITY; MATHEMATICAL COMPUTING; MAXIMUM LIKELIHOOD METHOD; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; VALIDATION STUDY;

EID: 34447319931     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btm110     Document Type: Article

References (32)

1. Arranz,M.J. et al. (2003) Pharmacogenetic and pharmacogenomic research in psychiatry: Current advances and clinical applications. Curr. Pharmacogenomics, 1, 151-158.
2. Burnham,K.P. and Andersson,D. (1998) Model Selection and Inference. A Practical Information-Theoretic Approach. Springer, New York.
3. Chagnon,Y.C. et al. (2003) The human obesity gene map: The 2002update. Obes. Res., 11, 313-367.
4. Churchill,G.A. and Doerge,W. (1994) Empirical threshold values for quantitative trait mapping. Genetics, 138, 963-971.
5. Frankel,W.N. and Schork,N.J. (1996) Who's afraid of epistasis? Nat. Genet., 14, 371-373.
6. Gabriel,K.R. (1962) Ante-dependence analysis of an ordered set of variables. Ann. Math. Stat., 33, 201-212.
7. Giraldo,J. (2003) Empirical models and Hill coefficients. Trends Pharmacolog. Sci., 24, 63-65.
8. Gong,Y. et al. (2004) A statistical model for functional mapping of quantitative trait loci regulating drug response. Pharmacogenomics J., 4, 315-321.
9. Gordon,D. et al. (2002) Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum. Hered., 54 22-33.
10. Green, S.A. et al. (1995) Implications of genetic variability of human 2-adrenergic receptor structure. Pulm. Pharmacol., 8, 1-10.
11. Kang,S.J. et al. (2004) Quantifying the percent increase in minimum sample size for SNP genotyping errors in genetic model-based association studies. Hum. Hered., 58, 139-144.
12. Lander,E.S. and Botstein,D. (1989) Mapping Mendelian factors underlying quantitative traits using RELP linkage maps. Genetics, 121, 185-199.
13. Large,V. et al. (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J. Clin. Invest., 100 3005-3013.
14. Lin,M. et al. (2005) Sequencing drug response with HapMap. Pharmacogenomics J., 5, 149-156.
15. Lin,M. and Wu,R.L. (2006) Detecting sequence-sequence interactions for complex diseases. Curr. Genomics, 7, 59-72.
16. Liu,T. et al. (2004) Sequencing complex diseases with HapMap. Genetics, 168, 503-511.
17. Lynch,M. and Walsh,B. (1998) Genetics and Analysis of Quantitative Traits. Sinauer, Sunderland, MA, USA.
18. Ma,C.-X. et al. (2002) Functional mapping of quantitative trait loci underlying the character process: A theoretical framework. Genetics, 161, 1751-1762.
19. Marchini,J. et al. (2005) Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet., 37 413-417.
20. Mason,D.A. et al. (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J. Biol. Chem., 274, 12670-12674.
21. Moore,J.H. (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered., 56, 73-82.
22. Noureddine,M.A. et al. (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum. Genet., 117, 27-33.
23. Serretti,A. and Artioli,P. (2003) Predicting response to lithium in mood disorders: Role of genetic polymorphisms. Am. J. Pharmacogenomics, 3, 17-30.
24. Tate,S.K. et al. (2005) Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc. Natl Acad. Sci. USA, 102, 5507-5512.
25. Wu,R.L. et al. (2002) Joint linkage and linkage disequilibrium mapping of quantitative trait loci in natural populations. Genetics 160, 779-792.
26. Wu,R.L. et al. (2003) Molecular dissection of allometry, ontogeny and plasticity: A genomic view of developmental biology. BioScience 53, 1041-1047.
27. Wu,R.L. et al. (2004a) A general framework for analyzing the genetic architecture of developmental characteristics. Genetics, 166, 1541-1551.
28. Wu,R.L. et al. (2004b) Functional mapping of quantitative trait loci underlying growth trajectories using a transform-both-sides logistic model. Biometrics, 60, 729-738.
29. Wu,R.L. et al. (2004c) A mechanistic model for genetic machinery of ontogenetic growth. Genetics, 168, 2383-2394.
30. Wu,R.L. and Lin,M. (2006) Functional mapping - how to map and study the genetic architecture of dynamic complex traits. Nat. Rev. Genet., 7, 229-237.
31. Zhao,W. et al. (2005) A non-stationary model for functional mapping of longitudinal quantitative traits. Bioinformatics, 21 2469-2477.
32. Zimmerman,D.L. and Núñez-Antón,V. (2001) Parametric modeling of growth curve data: An overview (with discussion). Test, 10, 1-73.